Touyun Biotech Group Limited (HKG:1332)
Hong Kong · Delayed Price · Currency is HKD 0.1230
+0.0020 (1.65%)
May 29, 2026, 1:57 PM HKT
Touyun Biotech Group Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 26.8 | -88.11 | -268.94 | -198.07 | -72.95 |
Depreciation & Amortization | 23.62 | 29.48 | 36.59 | 32.22 | 21.3 |
Other Amortization | - | - | - | 0.92 | 1.41 |
Loss (Gain) From Sale of Assets | -23.44 | 1.03 | 2.05 | 2.82 | 22.91 |
Asset Writedown & Restructuring Costs | 5.5 | - | 78.75 | - | - |
Loss (Gain) From Sale of Investments | -123.98 | 33.56 | 100.43 | 150.17 | 54.05 |
Stock-Based Compensation | 1.29 | 3.64 | 2.59 | 6.86 | 16.18 |
Provision & Write-off of Bad Debts | -0.11 | 3.9 | 2.48 | 7.9 | 0.46 |
Other Operating Activities | 36.21 | 7.21 | 10.81 | 0.11 | -67.51 |
Change in Accounts Receivable | -1.06 | 1.58 | 5.97 | 15.43 | -142.48 |
Change in Inventory | -0.06 | -9.88 | 3.22 | -2.85 | 0.98 |
Change in Accounts Payable | -1.68 | -3.25 | -12.27 | -25.6 | 34.87 |
Change in Other Net Operating Assets | -14.49 | 28.92 | 18.54 | -23.98 | 68.2 |
Operating Cash Flow | -29.64 | -49.98 | 2.18 | -26.37 | -53.81 |
Capital Expenditures | -1.16 | -3.66 | -17.13 | -12.93 | -163.51 |
Sale of Property, Plant & Equipment | 0.01 | 0.43 | 1.19 | 1.15 | 3.28 |
Divestitures | 12.15 | - | - | - | 152.08 |
Sale (Purchase) of Real Estate | - | - | - | - | -87.28 |
Investment in Securities | -20 | - | -55 | -5.47 | -52.3 |
Other Investing Activities | -0.38 | -1.42 | - | - | - |
Investing Cash Flow | -9.38 | -4.66 | -70.95 | -17.25 | -147.74 |
Short-Term Debt Issued | 2.78 | 13.08 | 7.66 | 13.9 | - |
Long-Term Debt Issued | 105.52 | 91.85 | 106.37 | 315.9 | 348.64 |
Total Debt Issued | 108.3 | 104.94 | 114.02 | 329.81 | 348.64 |
Short-Term Debt Repaid | -2.16 | - | -1.14 | -3.63 | -16.52 |
Long-Term Debt Repaid | -84.15 | -89.09 | -145.1 | -230.54 | -247.33 |
Total Debt Repaid | -86.31 | -89.09 | -146.24 | -234.18 | -263.85 |
Net Debt Issued (Repaid) | 21.99 | 15.85 | -32.21 | 95.63 | 84.79 |
Issuance of Common Stock | - | - | - | - | 31.27 |
Other Financing Activities | 5.33 | 20 | 6 | 7 | 7.12 |
Financing Cash Flow | 27.32 | 35.85 | -26.21 | 102.63 | 123.17 |
Foreign Exchange Rate Adjustments | 0.44 | 0.61 | 1.37 | 8.89 | -3.86 |
Net Cash Flow | -11.25 | -18.18 | -93.61 | 67.9 | -82.24 |
Free Cash Flow | -30.8 | -53.64 | -14.95 | -39.3 | -217.32 |
Free Cash Flow Margin | -45.99% | -53.86% | -7.53% | -12.44% | -76.66% |
Free Cash Flow Per Share | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 |
Cash Interest Paid | 9.68 | 9.7 | 7.59 | 18.76 | 31.06 |
Cash Income Tax Paid | 0.98 | - | 2.53 | 1.51 | 3.3 |
Levered Free Cash Flow | -47.37 | 21.17 | 7.01 | -28.85 | -89.05 |
Unlevered Free Cash Flow | -34.13 | 27.22 | 11.66 | -15.31 | -78.33 |
Change in Working Capital | 9 | -29.88 | 34.71 | -29.3 | -23.03 |